Trials / Terminated
TerminatedNCT00977912
Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies
Prevention of NEC in Preterm Infants With B. Lactis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 318 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 12 Hours – 48 Hours
- Healthy volunteers
- Accepted
Summary
The purpose of the trial is to demonstrate the effect of B. lactis in reducing the incidence of Necrotizing Enterocolitis (NEC) compared to placebo in preterm infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic supplementation | one capsule containing probiotics per day added to milk |
| DIETARY_SUPPLEMENT | Milk containing placebo | one capsule containing placebo per day added to milk |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2009-09-16
- Last updated
- 2013-11-25
Locations
3 sites across 1 country: South Africa
Source: ClinicalTrials.gov record NCT00977912. Inclusion in this directory is not an endorsement.